Stage at Diagnosis and Patient Delay among Breast Cancer Women in Kabul, Afghanistan
DOI:
https://doi.org/10.3889/oamjms.2022.8609Keywords:
Breast cancer, Delay, Stage at diagnosis, AfghanistanAbstract
Background: Breast cancer is the commonest cause of mortality among women. According to WHO in 2012, about 7400 women died because of cancers in Afghanistan.
Aim: To obtain information about clinical stages of breast cancer of women at the time of diagnosis in Kabul, Afghanistan.
Patient and Method: This was a cross-sectional study of 240 women diagnosed with breast cancer from March 2016 to March 2019. The diagnosis of breast cancer was made by the surgeon on the basis of physical examination and Biopsy/Pathological reports. Clinical staging of the tumor was recorded according to the tumor, nodal, and metastasis (TNM) classification. The gap between knowing the problem and consulting a physician (Patient delay) was categorized: less than 3 months, 3-6 months and more than 6 months.
Results:
The mean age of patients was 49.31 years (SD ± 11.80) ranging from 18 to 76 years. The Patient delay was more than 6 months (65%). Infiltrating ductal carcinoma was the commonest morphological type (76.7%). Breast cancer in left breast of patients was 52.1%. Stage II was higher in left and stage III in right breast. The majority of patients were in stage II & III at the time of diagnosis. All stages were frequent in fourth decades of age group. The association between the clinical stages of breast cancer at the time of diagnosis, the age and breast R/L involvement of the patients was significant (P<0.001). The association between clinical stage and marital status was not significant (P<0.953).
Conclusion:
Late referrals, diagnosis delay and advanced stages of breast cancer are still a serious problem in Afghanistan. Cancer in right breast should be given more attention because higher stages of the disease are expected. Awareness and social education is great need.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133-40. https://doi.org/10.1016/S1470-2045(00)00254-0 PMid:11902563 DOI: https://doi.org/10.1016/S1470-2045(00)00254-0
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660 PMid:33538338 DOI: https://doi.org/10.3322/caac.21660
Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. Breast cancer in limited‐resource countries: health care systems and public policy. Breast J. 2006;12:S54-69. https://doi.org/10.1111/j.1075-122X.2006.00203.x PMid:16430399 DOI: https://doi.org/10.1111/j.1075-122X.2006.00203.x
Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res. 2009;11(4):1-9. https://doi.org/10.1186/bcr2349 PMid:19664291 DOI: https://doi.org/10.1186/bcr2349
Wang L. Early diagnosis of breast cancer. Sensors. 2017;17(7):1572. https://doi.org/10.3390/s17071572 PMid:28678153 DOI: https://doi.org/10.3390/s17071572
Scanlon EF. The early diagnosis of breast cancer. Cancer. 1981;48(S1):523-6. https://doi.org/10.1002/1097-0142(19810715)48:1+<523:AID-CNCR2820481314>3.0.CO;2-D PMid:7272977 DOI: https://doi.org/10.1002/1097-0142(19810715)48:1+<523::AID-CNCR2820481314>3.0.CO;2-D
Jedy-Agba E, McCormack V, Olaomi O, Badejo W, Yilkudi M, Yawe T, et al. Determinants of stage at diagnosis of breast cancer in Nigerian women: Sociodemographic, breast cancer awareness, health care access and clinical factors. Cancer Causes Control. 2017;28(7):685-97. https://doi.org/10.1007/s10552-017-0894-y PMid:28447308 DOI: https://doi.org/10.1007/s10552-017-0894-y
Ermiah E, Abdalla F, Buhmeida A, Larbesh E, Pyrhönen S, Collan Y. Diagnosis delay in Libyan female breast cancer. BMC Res Notes. 2012;5(1):452. https://doi.org/10.1186/1756-0500-5-452 PMid:22909280 DOI: https://doi.org/10.1186/1756-0500-5-452
Seneviratne S, Lawrenson R, Harvey V, Ramsaroop R, Elwood M, Scott N, et al. Stage of breast cancer at diagnosis in New Zealand: Impacts of socio-demographic factors, breast cancer screening and biology. BMC Cancer. 2016;16(1):129. https://doi.org/10.1186/s12885-016-2177-5 PMid:26896237 DOI: https://doi.org/10.1186/s12885-016-2177-5
Unger-Saldaña K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465. https://doi.org/10.5306/wjco.v5.i3.465 PMid:25114860 DOI: https://doi.org/10.5306/wjco.v5.i3.465
Ahmadian M, Samah AA. Application of health behavior theories to breast cancer screening among Asian women. Asian Pac J Cancer Prev. 2013;14(7):4005-13. https://doi.org/10.7314/APJCP.2013.14.7.4005 PMid:23991945 DOI: https://doi.org/10.7314/APJCP.2013.14.7.4005
Dianatinasab M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M. Impact of social and clinical factors on diagnostic delay of breast cancer: A cross-sectional study. Medicine. 2016;95(38):e4704. https://doi.org/10.1097/MD.0000000000004704 PMid:27661018 DOI: https://doi.org/10.1097/MD.0000000000004704
Pakseresht S, Ingle GK, Garg S, Sarafraz N. Stage at diagnosis and delay in seeking medical care among women with breast cancer, Delhi, India. Iran Red Crescent Med J. 2014;16(12). https://doi.org/10.5812/ircmj.14490 PMid:25763229 DOI: https://doi.org/10.5812/ircmj.14490
Malik I. Clinico-pathological features of breast cancer in Pakistan. J Pak Med Assoc. 2002;52(3):100-3. PMid:12071063
Azamjah N, Soltan-Zadeh Y, Zayeri F. Global trend of breast cancer mortality rate: A 25-year study. Asian Pac J Cancer Prev. 2019;20(7):2015. PMid:31350959 DOI: https://doi.org/10.31557/APJCP.2019.20.7.2015
Bab S, Abdifard E, Elyasianfar S, Mohammadi P, Heidari M. Time trend analysis of breast cancer in Iran and its six topographical regions: A population-based study. J Med Life. 2019;12(2):140. https://doi.org/10.31557%2FAPJCP.2019.20.7.2015 PMid:31406515
Alwan N, Tawfeeq F, Maallah AS, Sattar S, Saleh W. The stage of breast cancer at the time of diagnosis: Correlation with the clinicopathological findings among Iraqi patients. J Neoplasm. 2017;2(3):22. DOI: https://doi.org/10.21767/2576-3903.100020
Kothari A, Fentiman I. 22. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57(3):200-3. PMid:12723724
Brzozowska A, Mazurkiewicz M, Duma D, Mazurkiewicz T, Brzozowski W. Reasons for delay in treatment of breast cancer detected due to breast self-examination in women from the Lubelskie region. Ginekol Pol. 2014;85(1):14-7. https://doi.org/10.17772/gp/1684 PMid:24505958 DOI: https://doi.org/10.17772/gp/1684
Ashing-Giwa KT, Padilla GV, Bohorquez DE, Tejero JS, Garcia M. Understanding the breast cancer experience of Latina women. J Psychosoc Oncol. 2006;24(3):19-52. https://doi.org/10.1300/J077v24n03_02 PMid:17088240 DOI: https://doi.org/10.1300/J077v24n03_02
Albrektsen G, Heuch I, Thoresen S. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: A register-based study in Norway. BMC Cancer. 2010;10(1):1-11. https://doi.org/10.1186/1471-2407-10-226 PMid:20492657 DOI: https://doi.org/10.1186/1471-2407-10-226
Pathak R, Jha A, Neupane P, Chalise S, Basnyat A. Histopathological evaluation of carcinoma of breast. J Pathol Nepal. 2016;6(11):922-7. DOI: https://doi.org/10.3126/jpn.v6i11.15674
Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East J Cancer. 2018;9(3):243-51.
Hinyard L, Wirth LS, Clancy JM, Schwartz T. The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis. Breast. 2017;32:13-7. https://doi.org/10.1016/j.breast.2016.12.008 PMid:28012410 DOI: https://doi.org/10.1016/j.breast.2016.12.008
Buja A, Lago L, Lago S, Vinelli A, Zanardo C, Baldo V. Marital status and stage of cancer at diagnosis: A systematic review. Eur J Cancer Care. 2018;27(1):e12755. https://doi.org/10.1111/ecc.12755 PMid:28850741 DOI: https://doi.org/10.1111/ecc.12755
Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treatment. 2005;93(1):41-7. https://doi.org/10.1007/s10549-005-3702-4 PMid:26894860 DOI: https://doi.org/10.1007/s10549-005-3702-4
Busk T, Clemmesen J. The frequencies of left-and right-sided breast cancer. Br J Cancer. 1947;1(4):345. https://doi.org/10.1038/bjc.1947.31 PMid:18906311 DOI: https://doi.org/10.1038/bjc.1947.31
Perkins CI, Hotes J, Kohler BA, Howe HL. Association between breast cancer laterality and tumor location, United States, 1994-1998. Cancer Causes Control. 2004;15(7):637-45. https://doi.org/10.1023/B:CACO.0000036171.44162.5f PMid:15280621 DOI: https://doi.org/10.1023/B:CACO.0000036171.44162.5f
Abdou Y, Gupta M, Asaoka M, Attwood K, Mateusz O, Gandhi S, et al. Abstract P2-09-09: Breast cancer arising on the left side is biologically more aggressive and has worse outcomes compared to the right side. Cancer Res. 2020;80(Suppl 4):2-9. https://doi.org/10.1158/1538-7445.SABCS19-P2-09-09 DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-09-09
Downloads
Published
How to Cite
License
Copyright (c) 2022 Mohammad Sayed Behrad, Firoozeddin Rashed, Attaullah Zarabi, Surya Saidi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
